Everolimus for the prevention of organ rejection in cardiac transplantation
Status In progress
Process STA pre-2018
Referral date 01 July 2009
Topic area
  • Cardiovascular
  • Surgical procedures

Provisional Schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC

Project Team

Communications manager: TBC
Executive Lead: TBC
Project manager: TBC
Technical Lead: TBC


Key events during the development of the guidance:

Date Update
6 April 2011 The Department of Health has asked us to carry out a single technology appraisal of everolimus within its licensed indication for the prevention of organ rejection in cardiac transplantation.

Following on from information received from the manufacturer, dates for this appraisal will be confirmed once regulatory approval timelines are established.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance